preval
asthma
dramat
increas
recent
decad
exacerb
asthma
larg
contributor
asthmarel
cost
primarili
caus
viral
atyp
bacteri
infect
rhinovirus
rv
common
virus
detect
asthma
exacerb
rv
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
viral
infect
earli
life
induc
wheez
associ
develop
asthma
later
life
atyp
bacteri
infect
mycoplasma
pneumonia
chlamydia
pneumonia
also
link
chronic
asthma
potenti
asthma
exacerb
articl
discuss
recent
develop
viral
infect
specif
rv
rsv
hmpv
atyp
bacteri
infect
caus
asthma
exacerb
includ
new
data
focus
host
immun
respons
airway
epitheli
cell
anim
model
infect
asthma
complex
diseas
consist
genet
environment
factor
character
dyspnea
cough
wheez
revers
episod
bronchoconstrict
airway
hyperreact
chronic
eosinophil
inflamm
mucu
hypersecret
year
million
asthma
exacerb
occur
unit
state
viral
infect
caus
major
exacerb
tabl
atyp
bacteri
infect
mycoplasma
pneumonia
chlamydia
pneumonia
also
associ
asthma
exacerb
well
chronic
asthma
tabl
review
articl
focu
role
viral
infect
specif
rhinovirus
rv
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
caus
asthma
exacerb
also
viral
infect
earli
life
lead
wheez
potenti
develop
asthma
addit
review
recent
data
suggest
atyp
bacteri
infect
pathogen
role
chronic
asthma
mani
year
viral
infect
associ
asthma
exacerb
determin
specif
viru
present
exacerb
difficult
serolog
tissu
cultur
infect
techniqu
sensit
howev
develop
use
revers
transcriptasepolymeras
chain
reaction
pcr
greatli
facilit
accur
reliabl
specif
way
distinguish
respiratori
virus
also
determin
viru
type
use
pcr
suggest
respiratori
viral
infect
respons
approxim
asthma
exacerb
children
exacerb
adult
mani
type
virus
rv
rsv
hmpv
influenza
parainfluenza
coronaviru
detect
respiratori
tract
secret
patient
asthma
exacerb
rv
infect
present
dramat
clinic
outcom
normal
individu
common
viru
detect
patient
asthma
exacerb
fact
approxim
patient
asthma
exacerb
rv
infect
wheez
induc
rv
rsv
hmpv
infect
earli
childhood
associ
develop
asthma
later
childhood
rv
positivesens
icosahedralshap
nonenvelop
singlestrand
rna
virus
picornavirida
famili
virus
rv
serotyp
categor
mani
differ
paramet
receptor
specif
homolog
nucleotid
sequenc
discrimin
base
receptor
specif
result
two
group
rv
major
minor
group
major
group
rv
eg
compris
serotyp
use
intercellular
adhes
molecul
icam
mean
entri
cell
minor
group
rv
eg
use
lowdens
lipoprotein
famili
receptor
mean
entri
use
nucleotid
sequenc
homolog
phylogenet
analysi
three
speci
rv
describ
rv
serotyp
tradit
classifi
two
group
rva
rvb
base
sequenc
rva
compos
differ
serotyp
rvb
compos
differ
serotyp
recent
howev
use
sophist
pcr
techniqu
third
speci
rv
describ
distinct
rvc
speci
contain
least
nine
serotyp
numer
studi
suggest
rv
potenti
preexist
allerg
inflamm
result
asthma
exacerb
grunberg
colleagu
show
experiment
intranas
infect
adult
mild
atop
asthma
caus
decreas
fev
maxim
day
infect
significantli
greater
compar
placeboinfect
individu
mild
atop
asthma
studi
experiment
infect
shown
patient
asthma
increas
level
interleukin
il
nasal
lavag
fluid
correl
level
airway
respons
contrast
unaffect
individu
increas
messag
colleagu
show
patient
atop
asthma
experiment
infect
increas
eosinophil
increas
bronchial
hypersensit
measur
provoc
concentr
histamin
requir
reduc
fev
exact
mechan
remain
unknown
studi
patient
asthma
highest
viral
load
decreas
level
ifng
increas
level
cell
bal
fluid
data
suggest
individu
asthma
increas
level
cytokin
may
increas
viral
replic
subsequ
increas
airway
inflamm
decreas
lung
function
rv
infect
earli
childhood
also
associ
lower
respiratori
tract
infect
wheez
develop
asthma
rv
detect
patient
lower
respiratori
tract
infect
associ
wheez
miller
colleagu
found
children
age
admit
hospit
respiratori
symptom
fever
rvc
infect
rv
posit
sampl
patient
rvc
infect
like
diagnosi
asthma
hospit
discharg
compar
patient
rva
infect
respect
howev
rv
infect
first
year
life
associ
wheez
age
asthma
age
rsv
infect
induc
wheez
first
year
life
compar
rhinoviru
infect
respect
may
provid
explan
rv
previous
determin
induc
wheez
infect
infanc
rv
infect
strongli
associ
hospit
asthma
one
studi
adult
hospit
asthma
respiratori
tract
secret
examin
time
admiss
also
followup
rv
significantli
associ
hospit
asthma
adjust
odd
ratio
popul
adjust
sever
asthma
subject
rv
infect
like
smoker
use
inhal
corticosteroid
adjust
odd
ratio
p
subject
without
rv
infect
green
colleagu
also
reveal
individu
allerg
asthma
infect
rv
increas
admiss
hospit
asthma
patient
dust
mite
allergen
primari
allergen
detect
subject
skin
test
panel
aeroallergen
therefor
determin
rv
infect
ongo
low
dose
dust
mite
exposur
result
increas
asthma
symptom
de
kluijver
colleagu
conduct
threearm
doubleblind
studi
lowdos
dust
mite
exposur
infect
patient
without
asthma
dust
mite
exposur
alon
result
decreas
fev
increas
eosinophil
bal
fluid
rv
infect
alon
decreas
fev
increas
product
neutrophil
howev
studi
show
synergist
decreas
fev
synergist
increas
sputum
neutrophil
neutrophil
elastas
lowdos
allergen
exposur
rv
infect
popul
mild
moder
asthma
studi
success
develop
experiment
model
includ
allergen
exposur
rv
infect
epidemiolog
data
clinic
data
patient
atop
asthma
experiment
infect
rv
show
associ
rv
infect
asthma
exacerb
rsv
singlestrand
envelop
negativesens
rna
viru
peak
infect
winter
month
rsv
usual
result
upper
respiratori
infect
infant
rsv
infect
caus
lower
respiratori
infect
lead
pneumonia
bronchiol
rsvinduc
bronchiol
lead
caus
wheez
infant
young
children
children
infect
rsv
result
bronchiol
four
time
like
develop
wheez
asthma
later
childhood
unknown
whether
rsv
increas
chanc
develop
asthma
peopl
predispos
asthma
like
develop
rsvinduc
bronchiol
nonetheless
studi
shown
correl
sever
rsv
bronchiol
develop
asthma
sigur
colleagu
report
infant
rsv
bronchiol
result
hospit
asthma
recurr
wheez
recurr
wheez
defin
three
episod
wheez
verifi
physician
prior
year
age
compar
control
subject
hmpv
hmpv
recent
isol
viru
paramyxoviru
close
relat
rsv
phylogenet
analysi
caus
respiratori
tract
infect
children
adult
hmpv
isol
children
hmpv
associ
asthma
exacerb
children
adult
studi
examin
respiratori
virus
nasalwash
specimen
children
respiratori
tract
infect
show
hmpv
detect
approxim
children
test
hmpv
infect
associ
asthma
exacerb
children
greater
year
age
found
associ
wheez
children
younger
year
age
patient
coinfect
rsvhmpv
increas
use
supplement
oxygen
associ
sever
bronchiol
adult
william
colleagu
detect
hmpv
nasal
wash
patient
admit
hospit
asthma
exacerb
studi
show
associ
hmpv
wheez
children
less
year
age
also
associ
hmpv
asthma
exacerb
adult
howev
children
greater
year
age
show
signific
associ
hmpv
infect
asthma
exacerb
reason
observ
differ
remain
unclear
airway
epitheli
cell
polar
cell
apic
basolater
surfac
provid
first
line
defens
pathogen
enter
airway
rv
rsv
primarili
infect
airway
epitheli
cell
activ
inflammatori
pathway
increas
proinflammatori
cytokin
chemokin
product
tumor
necrosi
factor
tnf
rant
granulocyt
macrophag
colonystimul
factor
gmcsf
increas
cytokin
chemokin
product
due
specif
activ
nuclear
factor
nf
kb
mitogenactiv
protein
kinas
mapk
pathway
increas
cytokin
chemokin
product
result
inflamm
influx
leukocyt
provid
possibl
mechan
exacerb
asthma
cultur
epitheli
cell
mucociliarydifferenti
primari
human
bronchial
epitheli
cell
simultan
expos
proinflammatori
cytokin
tnf
infect
synergist
increas
product
addit
increas
transactiv
transcript
factor
requir
maxim
product
nfkb
activ
data
correl
increas
bronchoalveolar
tnf
level
cooper
increas
experiment
infect
segment
allergen
challeng
allerg
patient
togeth
find
suggest
airway
epitheli
cell
may
respons
initi
robust
possibl
synergist
immun
respons
rv
rsv
infect
presenc
preexist
allerg
inflamm
activ
nfkb
mapk
pathway
product
cytokin
chemokin
recent
nonprim
model
rv
infect
avail
main
problem
develop
mous
model
rv
infect
receptor
major
group
rv
would
bind
mous
howev
mous
model
develop
major
minor
serotyp
rv
transgen
balbc
mice
mousehuman
chimera
success
infect
major
group
viru
minor
group
viru
capabl
bind
mous
lowdens
lipoprotein
receptor
gener
success
infect
vivo
infect
wildtyp
mice
chimera
transgen
mice
caus
increas
type
ifn
product
augment
product
chemokin
influx
inflammatori
cell
increas
express
lung
homogen
andor
bal
fluid
balbc
mice
sensit
challeng
intranas
allergen
ovalbumin
ova
infect
rvova
mice
rvova
mice
increas
bal
fluid
neutrophil
day
infect
lymphocyt
day
infect
compar
rvinfect
mice
ovasensit
challeng
mice
receiv
ultravioletirradi
airway
hyperrespons
also
increas
rvova
mice
day
infect
respons
mucac
increas
mice
infect
ovainduc
inflamm
mous
model
rsv
elucid
mechan
viru
caus
inflamm
airway
reactiv
studi
reveal
rsv
strain
differ
import
contributor
airway
inflamm
physiolog
paramet
infect
rsv
strain
strain
commonli
use
laboratori
absenc
preexist
allerg
inflamm
rsv
produc
lung
mucu
airway
reactiv
infect
howev
infect
anoth
rsv
strain
line
result
abund
product
lung
airway
mucu
increas
airway
reactiv
challeng
methacholin
model
rsv
infect
occur
set
ongo
allerg
inflamm
also
use
understand
viru
may
caus
asthma
exacerb
human
instanc
rsv
infect
increas
airway
reactiv
respons
methacholin
challeng
presenc
ongo
allerg
inflamm
induc
ova
cockroach
antigen
mice
lack
one
chemokin
receptor
decreas
airway
resist
cell
infiltr
lung
rsv
infect
cockroach
antigeninduc
allerg
inflamm
mucu
product
also
increas
rsv
infect
ongo
allerg
airway
inflamm
balbc
mice
unexpectedli
decreas
lung
cytokin
produc
cell
also
involv
mucu
product
synergist
increas
lung
mice
infect
rsv
ongo
allerg
inflamm
collect
data
suggest
strain
rsv
host
immun
respons
may
respons
increas
mucu
product
airway
inflamm
hmpv
abl
infect
balbc
mice
shown
caus
weight
loss
ruffl
fur
infect
mice
similar
rsv
howev
hmpv
replic
well
mice
tenfold
lower
viral
replic
compar
mice
infect
rsv
produc
robust
inflammatori
respons
therefor
comparison
studi
rsv
hmpv
difficult
interpret
virus
develop
mechan
evad
immun
system
establish
success
infect
downregul
cellular
transcript
product
type
ifn
nonstructur
ns
protein
rsv
shown
inhibit
ifna
ifnb
product
decreas
proinflammatori
transcript
factor
interferon
regulatori
factor
irf
nfkb
signal
transduc
activ
transcript
protein
stat
hmpv
contain
ns
protein
detect
level
ifna
bal
fluid
hour
day
infect
wherea
rsv
detect
level
day
infect
prolong
ifna
respons
provid
potenti
explan
small
amount
viral
replic
low
number
inflammatori
cell
bal
fluid
hmpvinfect
mice
recent
shown
cultur
airway
epitheli
cell
patient
asthma
decreas
ifnb
respons
infect
compar
cultur
airway
epitheli
cell
normal
control
subject
decreas
type
ifn
respons
led
increas
viral
titer
diminish
airway
epitheli
cell
apoptosi
similar
find
seen
mrna
level
type
iii
interferon
therefor
data
combin
suggest
preexist
allerg
inflamm
host
immun
respons
patient
asthma
may
lead
decreas
interferon
respons
result
success
infect
perhap
greater
symptom
pneumonia
c
pneumonia
atyp
bacteria
attach
airway
epitheli
cell
caus
cell
damag
similar
respiratori
virus
pneumonia
c
pneumonia
difficult
detect
vari
result
serolog
cultur
use
pcr
made
detect
sensit
although
invas
procedur
endobronchi
biopsi
still
normal
requir
definit
diagnosi
known
caus
respiratori
tract
infect
role
pneumonia
c
pneumonia
exacerb
asthma
remain
controversi
lieberman
colleagu
found
adult
patient
acut
asthma
exacerb
atyp
bacteria
infect
pneumonia
compar
control
patient
without
asthma
detect
pair
sera
test
use
immunofluoresc
enzym
immunoassay
method
studi
associ
c
pneumonia
asthma
exacerb
howev
studi
reveal
c
pneumonia
infect
correl
asthma
exacerb
martin
colleagu
examin
c
pneumonia
pneumonia
infect
upper
lower
airway
patient
chronic
asthma
use
pcr
patient
asthma
posit
c
pneumonia
pneumonia
compar
control
patient
without
asthma
pneumonia
found
patient
asthma
control
patient
pcr
patient
asthma
control
patient
pcrposit
c
pneumonia
therefor
c
pneumonia
increas
patient
asthma
compar
control
patient
data
suggest
may
preval
pneumonia
infect
clinic
studi
still
need
fulli
determin
link
atyp
bacteria
infect
asthma
exacerb
howev
anim
model
ovainduc
allerg
inflamm
infect
pneumonia
increas
collagen
deposit
day
infect
seen
pneumonia
infect
absenc
preexist
allergicinduc
inflamm
mechan
describ
asthmat
airway
suscept
pneumonia
still
remain
larg
unknown
wu
colleagu
found
tolllik
receptor
tlr
express
product
downregul
pneumonia
infect
ongo
ovainduc
allerg
inflamm
block
neutral
antibodi
restor
express
product
togeth
data
suggest
preexist
allerg
inflamm
impair
abil
upregul
lung
lead
decreas
clearanc
pneumonia
increas
airway
inflamm
addit
airway
epitheli
cell
subject
asthma
infect
mycoplasma
increas
express
compar
epitheli
cell
subject
without
asthma
posit
associ
atyp
bacteria
infect
asthma
exacerb
antibiot
gener
given
respons
chronic
asthma
recommend
asthma
exacerb
macrolid
ketolid
prescrib
pneumonia
c
pneumonia
infect
antiinflammatori
properti
make
difficult
determin
atyp
bacteria
play
role
asthma
exacerb
howev
kraft
colleagu
shown
patient
posit
pneumonia
c
pneumonia
chronic
asthma
increas
fev
treat
clarithromycin
week
telicast
studi
johnston
colleagu
show
patient
asthma
exacerb
given
telithromycin
ketolid
increas
symptomfre
day
lung
function
test
conduct
clinic
compar
control
subject
given
placebo
increas
lung
function
test
conduct
home
therefor
despit
correl
mycoplasma
infect
asthma
exacerb
chronic
asthma
research
need
conduct
determin
atyp
bacteria
infect
caus
exacerb
anoth
factor
persist
simultan
yet
independ
exacerb
although
viral
infect
atyp
bacteri
infect
associ
asthma
exacerb
individu
asthma
viral
infect
atyp
bacteria
infect
asthma
exacerb
therefor
precis
mechan
lead
condit
fulli
understood
research
need
conduct
